Shafer Bradford J 4
4 · Theravance Biopharma, Inc. · Filed Aug 9, 2018
Insider Transaction Report
Form 4
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
- Sale
Ordinary Shares
2018-08-07$28.03/sh−4,127$115,686→ 123,479 total - Sale
Ordinary Shares
2018-08-07$28.99/sh−1,818$52,707→ 127,606 total - Sale
Ordinary Shares
2018-08-08$27.85/sh−25,355$706,182→ 98,124 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices from $28.60 to $29.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices from $28.015 to $28.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices from $27.63 to $28.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.